Literature DB >> 26351237

Functional and neuropsychological late outcomes in posterior fossa tumors in children.

Alvaro Lassaletta1, Eric Bouffet1, Donald Mabbott2, Abhaya V Kulkarni3.   

Abstract

Tumors of the posterior fossa (PF) account for up to 60 % of all childhood intracranial tumors. Over the last decades, the mortality rate of children with posterior fossa tumors has gradually decreased. While survival has been the primary objective in most reports, quality of survival increasingly appears to be an important indicator of a successful outcome. Children with a PF tumor can sustain damage to the cerebellum and other brain structures from the tumor itself, concomitant hydrocephalus, the consequences of treatment (surgery, chemotherapy, radiotherapy), or a combination of these factors. Together, these contribute to long-term sequelae in physical functioning, neuropsychological late outcomes (including academic outcome, working memory, perception and estimation of time, and selective attention, long-term neuromotor speech deficits, and executive functioning). Long-term quality of life can also be affected by endocrinological complication or the occurrence of secondary tumors. A significant proportion of survivors of PF tumors require long-term special education services and have reduced rates of high school graduation and employment. Interventions to improve neuropsychological functioning in childhood PF tumor survivors include (1) pharmacological interventions (such as methylphenidate, modafinil, or donepezil), (2) cognitive remediation, and (3) home-based computerized cognitive training. In order to achieve the best possible outcome for survivors, and ultimately minimize long-term complications, new interventions must be developed to prevent and ameliorate the neuro-toxic effects experienced by these children.

Entities:  

Keywords:  Chemotherapy; Children; Craniospinal radiation; Neurocognitive outcome; Neuropsychological; Posterior fossa

Mesh:

Year:  2015        PMID: 26351237     DOI: 10.1007/s00381-015-2829-9

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  76 in total

1.  Lateralized cognitive deficits in children following cerebellar lesions.

Authors:  R B Scott; C J Stoodley; P Anslow; C Paul; J F Stein; E M Sugden; C D Mitchell
Journal:  Dev Med Child Neurol       Date:  2001-10       Impact factor: 5.449

2.  Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.

Authors:  Thomas E Merchant; Larry E Kun; Matthew J Krasin; Dana Wallace; Murali M Chintagumpala; Shiao Y Woo; David M Ashley; Maree Sexton; Stewart J Kellie; Verity Ahern; Amar Gajjar
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-24       Impact factor: 7.038

3.  Cognitive deficits in long-term survivors of childhood brain tumors: Identification of predictive factors.

Authors:  Tonny Solveig Reimers; Susanne Ehrenfels; Erik Lykke Mortensen; Marianne Schmiegelow; Signe Sønderkaer; Henrik Carstensen; Kjeld Schmiegelow; Jørn Müller
Journal:  Med Pediatr Oncol       Date:  2003-01

4.  Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort study.

Authors:  Wassim Chemaitilly; Zhenghong Li; Sujuan Huang; Kirsten K Ness; Karen L Clark; Daniel M Green; Nicole Barnes; Gregory T Armstrong; Matthew J Krasin; Deo Kumar Srivastava; Ching-Hon Pui; Thomas E Merchant; Larry E Kun; Amar Gajjar; Melissa M Hudson; Leslie L Robison; Charles A Sklar
Journal:  J Clin Oncol       Date:  2015-01-05       Impact factor: 44.544

5.  An analysis of SEER data of increasing risk of secondary malignant neoplasms among long-term survivors of childhood brain tumors.

Authors:  Katia M Peterson; Cheng Shao; Robert McCarter; Tobey J MacDonald; Julianne Byrne
Journal:  Pediatr Blood Cancer       Date:  2006-07       Impact factor: 3.167

6.  Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961.

Authors:  Roger J Packer; Tianni Zhou; Emi Holmes; Gilbert Vezina; Amar Gajjar
Journal:  Neuro Oncol       Date:  2012-10-25       Impact factor: 12.300

7.  Cerebral white matter integrity and executive function in adult survivors of childhood medulloblastoma.

Authors:  Tara M Brinkman; Wilburn E Reddick; Joshua Luxton; John O Glass; Noah D Sabin; Deo Kumar Srivastava; Leslie L Robison; Melissa M Hudson; Kevin R Krull
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

8.  Natural history of cavernous malformations in children with brain tumors treated with radiotherapy and chemotherapy.

Authors:  Angela Di Giannatale; Giovanni Morana; Andrea Rossi; Armando Cama; Luisella Bertoluzzo; Salvina Barra; Paolo Nozza; Claudia Milanaccio; Alessandro Consales; Maria Luisa Garrè
Journal:  J Neurooncol       Date:  2014-02-11       Impact factor: 4.130

9.  Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function.

Authors:  Thomas E Merchant; Chia-Ho Hua; Hemant Shukla; Xiaofei Ying; Simeon Nill; Uwe Oelfke
Journal:  Pediatr Blood Cancer       Date:  2008-07       Impact factor: 3.167

10.  Management of hydrocephalus complicating childhood posterior fossa tumors.

Authors:  M S Dias; A L Albright
Journal:  Pediatr Neurosci       Date:  1989
View more
  27 in total

1.  Quality of life in long-term survivors treated for metastatic medulloblastoma with a hyperfractionated accelerated radiotherapy (HART) strategy.

Authors:  L Veneroni; L Boschetti; F Barretta; C A Clerici; F Simonetti; E Schiavello; V Biassoni; F Spreafico; L Gandola; E Pecori; B Diletto; G Poggi; F Gariboldi; R Sensi; M Massimino
Journal:  Childs Nerv Syst       Date:  2017-08-02       Impact factor: 1.475

Review 2.  Improving diagnosis of pediatric central nervous system tumours: aiming for early detection.

Authors:  Ran D Goldman; Sylvia Cheng; D Douglas Cochrane
Journal:  CMAJ       Date:  2016-11-28       Impact factor: 8.262

3.  Survival and functional outcomes of molecularly defined childhood posterior fossa ependymoma: Cure at a cost.

Authors:  Michal Zapotocky; Kiran Beera; Jenny Adamski; Normand Laperierre; Sharon Guger; Laura Janzen; Alvaro Lassaletta; Liana Figueiredo Nobre; Ute Bartels; Uri Tabori; Cynthia Hawkins; Stacey Urbach; Derek S Tsang; Peter B Dirks; Michael D Taylor; Eric Bouffet; Donald J Mabbott; Vijay Ramaswamy
Journal:  Cancer       Date:  2019-02-15       Impact factor: 6.860

4.  Neuropsychological phenotypes of 76 individuals with Joubert syndrome evaluated at a single center.

Authors:  Angela C Summers; Joseph Snow; Edythe Wiggs; Alexander G Liu; Camilo Toro; Andrea Poretti; Wadih M Zein; Brian P Brooks; Melissa A Parisi; Sara Inati; Dan Doherty; Meghana Vemulapalli; Jim C Mullikin; Thierry Vilboux; William A Gahl; Meral Gunay-Aygun
Journal:  Am J Med Genet A       Date:  2017-05-12       Impact factor: 2.802

5.  Exercise training for neural recovery in a restricted sample of pediatric brain tumor survivors: a controlled clinical trial with crossover of training versus no training.

Authors:  Lily Riggs; Janine Piscione; Suzanne Laughlin; Todd Cunningham; Brian W Timmons; Kerry S Courneya; Ute Bartels; Jovanka Skocic; Cynthia de Medeiros; Fang Liu; Nicholas Persadie; Katrin Scheinemann; Nadia Scantlebury; Kamila U Szulc; Eric Bouffet; Donald J Mabbott
Journal:  Neuro Oncol       Date:  2017-03-01       Impact factor: 12.300

6.  Impaired Recent, but Preserved Remote, Autobiographical Memory in Pediatric Brain Tumor Patients.

Authors:  Melanie J Sekeres; Lily Riggs; Alexandra Decker; Cynthia B de Medeiros; Agnes Bacopulos; Jovanka Skocic; Kamila Szulc-Lerch; Eric Bouffet; Brian Levine; Cheryl L Grady; Donald J Mabbott; Sheena A Josselyn; Paul W Frankland
Journal:  J Neurosci       Date:  2018-08-20       Impact factor: 6.167

7.  Motor Functioning and Intelligence Quotient in Paediatric Survivors of a Fossa Posterior Tumor Following a Multidisciplinary Rehabilitation Program.

Authors:  Mathieu Decock; Robin De Wilde; Ruth Van der Looven; Catharine Vander Linden
Journal:  Int J Environ Res Public Health       Date:  2022-06-09       Impact factor: 4.614

Review 8.  Posterior Fossa Tumor Rehabilitation: An Up-to-Date Overview.

Authors:  Daniela Pia Rosaria Chieffo; Federica Lino; Valentina Arcangeli; Federica Moriconi; Paolo Frassanito; Luca Massimi; Gianpiero Tamburrini
Journal:  Children (Basel)       Date:  2022-06-16

9.  Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.

Authors:  Vijay Ramaswamy; Thomas Hielscher; Stephen C Mack; Alvaro Lassaletta; Tong Lin; Kristian W Pajtler; David T W Jones; Betty Luu; Florence M G Cavalli; Kenneth Aldape; Marc Remke; Martin Mynarek; Stefan Rutkowski; Sridharan Gururangan; Roger E McLendon; Eric S Lipp; Christopher Dunham; Juliette Hukin; David D Eisenstat; Dorcas Fulton; Frank K H van Landeghem; Mariarita Santi; Marie-Lise C van Veelen; Erwin G Van Meir; Satoru Osuka; Xing Fan; Karin M Muraszko; Daniela P C Tirapelli; Sueli M Oba-Shinjo; Suely K N Marie; Carlos G Carlotti; Ji Yeoun Lee; Amulya A Nageswara Rao; Caterina Giannini; Claudia C Faria; Sofia Nunes; Jaume Mora; Ronald L Hamilton; Peter Hauser; Nada Jabado; Kevin Petrecca; Shin Jung; Luca Massimi; Massimo Zollo; Giuseppe Cinalli; László Bognár; Almos Klekner; Tibor Hortobágyi; Sarah Leary; Ralph P Ermoian; James M Olson; Jeffrey R Leonard; Corrine Gardner; Wieslawa A Grajkowska; Lola B Chambless; Jason Cain; Charles G Eberhart; Sama Ahsan; Maura Massimino; Felice Giangaspero; Francesca R Buttarelli; Roger J Packer; Lyndsey Emery; William H Yong; Horacio Soto; Linda M Liau; Richard Everson; Andrew Grossbach; Tarek Shalaby; Michael Grotzer; Matthias A Karajannis; David Zagzag; Helen Wheeler; Katja von Hoff; Marta M Alonso; Teresa Tuñon; Ulrich Schüller; Karel Zitterbart; Jaroslav Sterba; Jennifer A Chan; Miguel Guzman; Samer K Elbabaa; Howard Colman; Girish Dhall; Paul G Fisher; Maryam Fouladi; Amar Gajjar; Stewart Goldman; Eugene Hwang; Marcel Kool; Harshad Ladha; Elizabeth Vera-Bolanos; Khalida Wani; Frank Lieberman; Tom Mikkelsen; Antonio M Omuro; Ian F Pollack; Michael Prados; H Ian Robins; Riccardo Soffietti; Jing Wu; Phillipe Metellus; Uri Tabori; Ute Bartels; Eric Bouffet; Cynthia E Hawkins; James T Rutka; Peter Dirks; Stefan M Pfister; Thomas E Merchant; Mark R Gilbert; Terri S Armstrong; Andrey Korshunov; David W Ellison; Michael D Taylor
Journal:  J Clin Oncol       Date:  2016-06-06       Impact factor: 44.544

10.  Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study report.

Authors:  Elizabeth M Wells; Nicole J Ullrich; Kristy Seidel; Wendy Leisenring; Charles A Sklar; Gregory T Armstrong; Lisa Diller; Allison King; Kevin R Krull; Joseph P Neglia; Marilyn Stovall; Kimberly Whelan; Kevin C Oeffinger; Leslie L Robison; Roger J Packer
Journal:  Neuro Oncol       Date:  2018-01-10       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.